Although COVID-19 outcomes have improved over the pandemic for patients with RA, some
experience poor acute and postacute outcomes after COVID-19. Clinicians and patients …

Background Some patients with systemic autoimmune rheumatic disease and
immunosuppression might still be at risk of severe COVID-19. The effect of outpatient SARS …

Objectives This study aimed to conduct a comprehensive systematic literature review and
meta-analysis to assess the risk and outcomes of coronavirus disease 2019 (COVID-19) in …

Objective To compare the risk of SARS-CoV-2 infection and its related severe sequelae
between patients with systemic lupus erythematosus (SLE) and the general population …

Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs)
in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) …

Objectives: To investigate COVID-19 breakthrough infection after third mRNA vaccine dose
among patients with RA by immunomodulator drug class, and we hypothesized that CD20 …

Objective To investigate risk factors and outcomes of repeat COVID-19 infections among
patients with systemic autoimmune rheumatic diseases (SARDs). Methods We performed a …

Objectives To investigate the effects of SARS-CoV-2 infection, as well as short-(within 48
hours) and long-term (within 30 days) adverse events (AEs) of SARS-CoV-2 vaccines …

Objectives Patients with RA were at increased risk for COVID-19-associated hospitalization
and death during the first year of the pandemic in Greece. We aimed to examine their …

Background As most people now have established hybrid immunity, the need for regular,
updated SARS-CoV-2 vaccine boosters in patients with immune-mediated inflammatory …